^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    zimlovisertib (PF-06650833)

    i
    Other names: PF-06650833, PF 6650833, PF-6650833, PF 06650833, PF06650833, PF6650833
    Associations
    News
    Trials
    Company:
    Pfizer
    Drug class:
    IRAK-4 inhibitor
    Related drugs:
    Associations
    News
    Trials